FR2129656A5 - - Google Patents

Info

Publication number
FR2129656A5
FR2129656A5 FR7208845A FR7208845A FR2129656A5 FR 2129656 A5 FR2129656 A5 FR 2129656A5 FR 7208845 A FR7208845 A FR 7208845A FR 7208845 A FR7208845 A FR 7208845A FR 2129656 A5 FR2129656 A5 FR 2129656A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7208845A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of FR2129656A5 publication Critical patent/FR2129656A5/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7208845A 1971-03-16 1972-03-14 Expired FR2129656A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB696371A GB1389662A (en) 1971-03-16 1971-03-16 Biological test

Publications (1)

Publication Number Publication Date
FR2129656A5 true FR2129656A5 (fr) 1972-10-27

Family

ID=9824046

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7208845A Expired FR2129656A5 (fr) 1971-03-16 1972-03-14

Country Status (12)

Country Link
US (1) US3816263A (fr)
JP (1) JPS5432357B1 (fr)
AT (1) AT334325B (fr)
BE (1) BE780592A (fr)
CA (1) CA969457A (fr)
CH (1) CH587916A5 (fr)
DE (1) DE2212285C3 (fr)
FR (1) FR2129656A5 (fr)
GB (1) GB1389662A (fr)
NL (1) NL176792C (fr)
SE (1) SE406646B (fr)
ZA (1) ZA721457B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988115A (en) * 1975-09-18 1976-10-26 Modabber Farrokh Z Diagnostic method for determining pathological condition by antigen-combining capacity of lymphocytes
US4072574A (en) * 1976-07-30 1978-02-07 The Institute For Cancer Research System for in vitro assay for mutagenicity and/or carcinogenicity of chemicals or other exogenous agents
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4345026A (en) * 1981-01-12 1982-08-17 The Children's Hospital Medical Center Mutagenicity assay
US5413915A (en) * 1988-07-12 1995-05-09 Resource Technologies Group, Inc. Method and sensor for detecting toxic chemical exposure effects and metabolic activation of carcinogenic chemical agents
FR2681327B1 (fr) * 1991-09-16 1993-12-24 Institut Nal Sante Recherc Medic Proteines capables notamment de constituer des facteurs de regulation fonctionnelle de la cellule et leurs applications biologiques.
US6773885B1 (en) * 2000-09-29 2004-08-10 Integrated Dna Technologies, Inc. Compositions and methods for visual ribonuclease detection assays

Also Published As

Publication number Publication date
BE780592A (fr) 1972-09-13
GB1389662A (en) 1975-04-03
JPS5432357B1 (fr) 1979-10-13
NL176792C (nl) 1985-06-03
ATA213572A (de) 1976-05-15
US3816263A (en) 1974-06-11
NL176792B (nl) 1985-01-02
AT334325B (de) 1976-01-10
DE2212285A1 (de) 1972-10-26
DE2212285C3 (de) 1981-02-12
DE2212285B2 (de) 1980-05-22
NL7203383A (fr) 1972-09-19
CH587916A5 (fr) 1977-05-13
SE406646B (sv) 1979-02-19
CA969457A (en) 1975-06-17
ZA721457B (en) 1972-11-29

Similar Documents

Publication Publication Date Title
FR2129656A5 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU2894671A (fr)
AU2684071A (fr)
AU3038671A (fr)
AU2455871A (fr)
AU2880771A (fr)
AU2684171A (fr)
AU2885171A (fr)
AU2588771A (fr)
AU2907471A (fr)
AU2669471A (fr)
AU2927871A (fr)
AU2930871A (fr)
AU2938071A (fr)
AU2940971A (fr)
AU2726271A (fr)
AU2724971A (fr)
AU2963771A (fr)
AU2654071A (fr)
AU2706571A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse